Gefticip 250mg 10 Tablets

Babies: Not applicable. Lactating mothers: It is unsafe to use this medicine during breastfeeding. Studies have shown that the drug causes harmful effects on the baby. Pregnancy: It is unsafe to use this medicine during pregnancy.
Human studies have shown that the drug causes harmful effects on the developing baby. Seek the doctor's advice before using this medicine. Alcohol: It is unsafe to consume alcohol while taking this medicine is limited.
Please consult your doctor before taking this medicine. Driving: This medicine causes weakness. Do not drive if you experience the symptoms that alter your ability to drive.
Kidney: This medicine should be, used with caution in patients with severe kidney disease. Dose adjustment is required.
Seek a doctor's advice before taking this medicine. Liver: It is safe to use this medicine in patients with liver disease. Dose adjustment is not required.
Seek a doctor's advice before using this medicine..

Diarrhea Dry skin Loss of appetite Nausea Rash Stomatitis (Inflammation of the mouth) Vomiting Weakness Weight loss.

Gefticip tablet is an antineoplastic medication used to treat small cell lung cancer. It works by inhibiting the action of the abnormal protein that is required for cancer cells to multiply..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine as prescribed by your doctor. • To get better results to take this medicine at a fixed time. • Finish the course of this medicine. • Do not stop taking this medicine suddenly without consulting your doctor. • If you experience mouth ulcers, changes in vision, and breathing difficulties while taking this medicine, inform your doctor. • Both males and females must follow effective contraceptive measures to avoid pregnancy while taking this medicine..

Major • Gefticip + Leflunomide: Concurrent use of these medicines lead to an increase in the risk of liver problems • Gefticip + Teriflunomide: Concurrent use of these medicines lead to an increase in the risk of liver problems • Gefticip + Aminolevulinic acid: Concurrent use of these medicines lead to an increase in the risk of severe sunburn Moderate • Gefticip + Amiodarone: Concurrent use of these medicines led to an increase in the therapeutic effect of gefticip • Gefticip + Aprepitant: Concurrent use of these medicines led to an increase in the therapeutic effect of gefticip • Gefticip + Aripiprazole: Concurrent use of these medicines led to an increase in the risk of drowsiness • Gefticip + Carbamazepine: Concurrent use of these medicines lead to a decrease in the therapeutic effect of gefticip • Gefticip + Ciprofloxacin: Concurrent use of these medicines lead to a decrease in the therapeutic effect of gefticip.